Related by context. All words. (Click for frequent words.) 78 pertuzumab 76 HGS ETR1 76 Aflibercept 76 HGS ETR2 75 pomalidomide 75 evaluating tivozanib 75 iniparib 75 sorafenib Nexavar 75 axitinib 75 HGS# 75 pegylated liposomal doxorubicin 74 erlotinib Tarceva ® 74 docetaxel Taxotere ® 74 MAGE A3 ASCI 74 motesanib 74 virus HCV protease inhibitor 74 carboplatin paclitaxel 74 YONDELIS 74 adalimumab Humira 74 5 FU leucovorin 74 metastatic castration resistant 73 BRAF inhibitor 73 ritonavir boosted 73 bevacizumab Avastin ® 73 temsirolimus 73 trastuzumab Herceptin R 73 MGd 73 AEGR 73 Velcade bortezomib 73 lumiliximab 73 oral prodrug 73 docetaxel Taxotere R 73 enzastaurin 73 elotuzumab 73 Taxotere chemotherapy 73 Nexavar sorafenib 73 idarubicin 73 IMC A# 73 Zolinza 73 dasatinib Sprycel ® 73 Imprime PGG 73 Epratuzumab 73 PXD# 73 alfa 2a 73 cetuximab Erbitux ® 73 Aliskiren 73 PEG SN# 72 SCH # 72 thalidomide Thalomid 72 galiximab 72 standard chemotherapy regimen 72 Fludara 72 Folfox 72 lapatinib Tykerb 72 Doxil ® 72 KRN# 72 cediranib 72 cabazitaxel 72 ZOLINZA 72 gemcitabine Gemzar 72 CIMZIA TM 72 sorafenib tablets 72 Cloretazine 72 ixabepilone 72 pegylated interferon alpha 72 docetaxel Taxotere 72 FOLFOX6 72 APTIVUS r 72 Targretin 72 cetuximab Erbitux R 72 Golimumab 72 HGS ETR1 mapatumumab 72 Pemetrexed 72 PKC# 72 vorinostat 71 FOLFOX chemotherapy 71 vandetanib 71 FOLFIRI 71 bortezomib Velcade R 71 relapsed MM 71 ACTEMRA TM 71 docetaxel chemotherapy 71 Herceptin trastuzumab 71 Pazopanib 71 alvespimycin 71 Tarceva TM 71 adriamycin 71 dacarbazine 71 dasatinib Sprycel 71 sorafenib Nexavar ® 71 gemcitabine carboplatin 71 fosbretabulin 71 Amrubicin 71 imatinib Gleevec ® 71 OMP #M# 71 FOLFOX6 chemotherapy regimen 71 nab paclitaxel 71 AEG# 71 mycophenolate mofetil 71 forodesine 71 Panzem R NCD 71 velafermin 71 Ixempra 71 Elotuzumab 71 Pegylated Interferon 71 aflibercept VEGF Trap 71 anidulafungin 71 Zybrestat 71 phase IIb clinical 71 Camptosar ® 71 HER2 positive metastatic breast 71 Ozarelix 71 Irinotecan 70 regorafenib 70 Mitoxantrone 70 PSMA ADC 70 Gemcitabine 70 DAVANAT 70 panitumumab Vectibix 70 CA4P 70 Traficet EN 70 Lacosamide 70 pegylated interferon alfa 2a 70 teriflunomide 70 receptor tyrosine kinase inhibitor 70 Archexin 70 S/GSK# 70 FOLFOX4 70 Bezielle 70 tanespimycin 70 metastatic hormone refractory 70 dacetuzumab 70 GW# [003] 70 neratinib 70 Omacetaxine 70 interferon gamma 1b 70 sunitinib Sutent ® 70 paclitaxel Taxol 70 cyclophosphamide chemotherapy 70 riociguat 70 cetuximab Erbitux 70 cilengitide 70 DOXIL 70 aflibercept 70 ribavirin RBV 70 Phase 2b Clinical Trial 70 Dasatinib 70 metastatic renal cell carcinoma 70 Glufosfamide 70 pan HDAC inhibitor 70 BZL# 70 refractory chronic lymphocytic 70 BAY #-# 70 telaprevir dosed 70 milatuzumab 70 TELCYTA 70 MyVax R 70 lenalidomide dexamethasone 70 estramustine 70 dexamethasone Decadron 70 Aptivus ® 70 Romidepsin 70 oral deforolimus 70 Cethromycin 70 Proxinium TM 70 relapsed multiple myeloma 70 ganetespib 70 Sym# 70 plus dexamethasone 70 tenofovir emtricitabine 70 NXL# 70 sunitinib malate 70 Fulvestrant 70 alkylating agent 70 Taxotere ® 70 Sapacitabine 70 Meets Primary Endpoint 70 active comparator 70 Erbitux cetuximab 70 cell lymphoma CTCL 70 Alocrest 70 Antitumor Activity 70 mRCC 69 investigational protease inhibitor 69 Gleevec imatinib mesylate 69 gemcitabine chemotherapy 69 talabostat 69 plus prednisone 69 bicalutamide 69 goserelin 69 FOLOTYN ® 69 SPRYCEL ® 69 refractory AML 69 trastuzumab DM1 69 imatinib Gleevec 69 valopicitabine 69 Seliciclib 69 demonstrated antitumor activity 69 PSN# [002] 69 oral ridaforolimus 69 bendamustine 69 Tyrima 69 #I TM# 69 Blinatumomab 69 CBLC# 69 Panzem 69 nucleoside analog 69 recurrent glioblastoma multiforme 69 Xeloda ® 69 Vidaza azacitidine 69 Peg IFN 69 CYT# potent vascular disrupting 69 pegylated interferon peg IFN 69 Exherin TM 69 Copegus ribavirin 69 gefitinib Iressa 69 PREZISTA r 69 Chemophase 69 Xcytrin 69 mertansine 69 trastuzumab Herceptin ® 69 trabectedin 69 K ras mutations 69 CIMZIA TM certolizumab pegol 69 histone deacetylase HDAC inhibitor 69 sunitinib Sutent 69 metaglidasen 69 Darusentan 69 Jevtana 69 adecatumumab 69 Annamycin 69 CR# vcMMAE 69 decitabine 69 atazanavir sulfate 69 MGCD# [001] 69 HCV RESPOND 2 69 sorafenib 69 Panitumumab 69 IMA# 69 Gemzar gemcitabine 69 Nexavar ® 69 Telbivudine 69 baminercept 69 gemcitabine cisplatin 69 Azedra 69 cisplatin gemcitabine 69 LAF# 69 rilonacept 69 oxaliplatin Eloxatin 69 cisplatin vinorelbine 69 alpha 2a 69 alefacept 69 APTIVUS 69 capecitabine Xeloda R 69 CCX# 69 PegIFN RBV 69 Erlotinib 69 imatinib therapy 69 PEGylated Fab fragment 69 Avastin bevacizumab 69 OMP #R# 69 TELINTRA 69 Torisel 69 Genentech Rituxan 69 systemic RNAi therapeutic 69 Pertuzumab 69 vicriviroc 69 anakinra 69 Capecitabine 69 INCB# [001] 69 bicifadine 69 bortezomib Velcade ® 69 cyclophosphamide doxorubicin vincristine 69 gadobutrol 69 Panzem NCD 69 Hormone Refractory Prostate Cancer 69 Ambrisentan 69 rituximab Rituxan 69 investigational monoclonal antibody 69 Carfilzomib 69 Viramidine 69 bortezomib 69 lenalidomide Revlimid R 69 infusional 5-FU/LV 69 OXi# 69 Doxil 68 VNP#M 68 pharmacokinetic PK study 68 liposomal doxorubicin 68 ZACTIMA 68 Temsirolimus 68 Melphalan 68 Vandetanib 68 PD LID 68 overlapping toxicities 68 PEGylated interferon beta 1a 68 viral kinetics 68 Gleevec resistant 68 pegylated interferon alfa 2b 68 chlorambucil 68 FUSILEV enhances 68 Revlimid lenalidomide 68 imatinib resistant 68 phase IIb trial 68 interferon alfa 68 OncoVEX GM CSF 68 tocilizumab 68 bevacizumab Avastin 68 Noxafil 68 Bortezomib 68 Gemzar ® 68 dose cytarabine 68 prostate cancer CRPC 68 amrubicin 68 azacitidine 68 posaconazole 68 midstage clinical 68 Tezampanel 68 metastatic colorectal 68 Bevacizumab 68 dasatinib 68 EndoTAG TM -1 68 Taxol paclitaxel 68 Asentar 68 low dose cytarabine 68 boosted protease inhibitor 68 erlotinib Tarceva 68 Deforolimus 68 crizotinib PF # 68 oblimersen 68 AVE# 68 Gleevec imatinib 68 DMARDs 68 Tarceva erlotinib 68 Darinaparsin 68 TORISEL 68 FOLPI 68 indolent NHL 68 peg interferon 68 mitoxantrone plus 68 TLK# 68 Pfizer Sutent 68 CoFactor 68 temozolomide TMZ 68 oral rivaroxaban 68 uric acid lowering 68 Degarelix 68 Teriflunomide 68 LymphoStat B belimumab 68 anti EGFR antibody 68 TO AVOID PREGNANCY WHILE 68 Roche Chugai s 68 leukemia CLL 68 Peginterferon alfa 2b 68 comparator arm 68 zalutumumab 68 paclitaxel Taxol R 68 NS#/#A protease 68 INCB# [003] 68 EOquin 68 EFAPROXYN 68 ELOXATIN 68 ALK inhibitor 68 olaparib 68 Navelbine 68 Panzem R 68 CD# monoclonal antibody 68 Voreloxin 68 CANCIDAS 68 radiation sensitizer 68 Interferon Beta 68 Ceflatonin 68 Safinamide 68 dextromethorphan quinidine 68 ELACYT 68 leukemia AML 68 ritonavir boosted atazanavir 68 Iressa gefitinib 68 sunitinib 68 FOLFOX 68 etanercept Enbrel 68 Vaprisol 68 Pegintron 68 Romiplostim 68 Phase Ib II 68 CTAP# Capsules 68 desvenlafaxine succinate 68 IMC #B 68 Boceprevir 68 Vitaxin 68 Vidaza ® 68 antibody MAb 68 investigational humanized monoclonal antibody 68 ZK EPO 68 lintuzumab 68 MabCampath 68 abiraterone acetate 68 Onrigin 68 Enzastaurin 68 bevacizumab Avastin R 68 EOquin TM 68 hormone refractory metastatic prostate 68 HuLuc# 68 Taxotere docetaxel 68 NATRECOR R 68 glufosfamide 68 Perifosine 68 TTF Therapy 68 PRT# 68 Gefitinib 68 BARACLUDE ® 68 irinotecan doxorubicin oxaliplatin paclitaxel 68 micafungin 68 refractory multiple myeloma 68 fluoropyrimidine 68 refractory gout 68 AQ4N 68 HCV SPRINT 68 DFMO 68 phase IIa clinical 68 paclitaxel Taxol ® 68 nitazoxanide 68 corticosteroid dexamethasone 68 5 fluorouracil leucovorin 68 Xelox 68 anthracycline taxane 68 Muraglitazar 68 Maribavir 68 GRN# 68 AZILECT R 68 davunetide intranasal AL 68 TKI therapy 67 Phase 1b trial 67 compound INCB# 67 AZILECT 67 diabetic neuropathic pain 67 R#/MEM # 67 anti leukemic 67 selective modulator 67 denileukin diftitox 67 bosutinib 67 Triapine R 67 APOPTONE 67 superficial bladder cancer 67 Triolex 67 relapsed refractory multiple myeloma 67 protease inhibitor PI 67 Navelbine ® 67 Peginterferon 67 CINTREDEKIN BESUDOTOX 67 IRX 2 67 ongoing Phase 1b 67 efavirenz EFV 67 GRN#L 67 docetaxel 67 amifostine 67 metastatic GIST 67 SAR# [004] 67 Rituxan rituximab 67 mTOR inhibitor 67 brivaracetam 67 pegylated interferon alfa 67 FEMALES SHOULD BE ADVISED 67 Taxotere R 67 Tipranavir 67 metastatic RCC 67 liposomal formulation 67 GSK# [002] 67 tipranavir 67 AVASTIN 67 perampanel 67 inhibitor RG# 67 Telintra 67 bortezomib Velcade 67 Sprycel dasatinib 67 Fludara ® 67 Talactoferrin 67 Azacitidine 67 relapsed ovarian cancer 67 GVAX 67 Reolysin 67 T DM1 67 maximally tolerated dose 67 interferon alfa 2a 67 vidofludimus 67 huC# DM4 67 CYC# 67 IMiDs 67 EGFR TKI 67 mecamylamine 67 PegIntron 67 peg IFN 67 XmAb# 67 refractory CLL 67 Cloretazine ® 67 fluorouracil 67 VAPRISOL 67 Roche Pegasys 67 proteasome inhibitor 67 ImClone Erbitux 67 recurrent NSCLC 67 raltegravir 67 generation Hsp# inhibitor 67 nilotinib 67 CEQ# 67 phase III isavuconazole 67 Oral Fingolimod 67 Laquinimod 67 peginterferon alfa 2a 67 invasive candidiasis 67 topotecan 67 Pimavanserin 67 levosimendan 67 Quinamed 67 histone deacetylase inhibitor 67 tipifarnib 67 irinotecan chemotherapy 67 lenalidomide Revlimid 67 Dapagliflozin 67 AstraZeneca Iressa 67 Neuvenge 67 CXB# 67 PEG IFN 67 q8h 67 R sorafenib tablets 67 Cetrorelix 67 ALGRX 67 Anthracycline 67 mitoxantrone 67 gastrointestinal stromal tumors GIST 67 pegylated interferons 67 pemetrexed Alimta 67 PEGINTRON TM 67 stage IIIB 67 sorafenib Nexavar R 67 immunomodulator 67 advanced metastatic renal 67 paclitaxel cisplatin 67 mitomycin 67 pharmacodynamic effects 67 Arranon 67 LymphoStat B TM 67 protein kinase inhibitor 67 gemcitabine Gemzar ® 67 DU #b 67 REOLYSIN ® 67 Phase 2a Clinical Trial 67 GSK# [001] 67 docetaxel prednisone 67 plasma kallikrein inhibitor 67 IAP inhibitors 67 refractory acute myeloid 67 peginterferon alpha 2a 67 abacavir lamivudine 67 antidiabetic 67 Vidofludimus 67 recurrent GBM 67 favorable pharmacokinetic profile 67 Telcyta 67 Randomized Phase 67 thymalfasin 67 Mylotarg 67 antimetabolite 67 dexpramipexole 67 MYDICAR ® 67 lopinavir r 67 humanised monoclonal antibody 67 Pegasys ® 67 beta 1a 67 JAK inhibitor 67 celgosivir 67 HSP# inhibitor 67 nilotinib Tasigna ® 67 Vicinium TM 67 cancer mCRC 67 standard chemotherapy regimens 67 Afatinib 67 gemcitabine 67 DEB# 67 beta interferons 67 Aclidinium 67 castrate resistant prostate cancer 67 peginterferon 67 Phase #b/#a clinical 67 PDX pralatrexate 67 CYT# 67 Peginterferon Alfa 2a 67 Myelodysplastic Syndrome MDS 67 nucleoside reverse transcriptase inhibitor 67 IL# PE#QQR 67 HuMax EGFr 67 ISENTRESS 67 Onconase 67 COPEGUS 67 Virulizin ® 67 Femara letrozole 67 ATACAND 67 eltrombopag 67 Aplidin 67 primary hypercholesterolemia 67 clodronate 67 JAK Inhibitor 67 oral antiviral 67 Pegasys peginterferon alfa 2a 67 multi kinase inhibitor 67 etoposide 67 Telavancin 67 irbesartan 67 TBC# 67 Trastuzumab 67 ocular formulation 67 CLORETAZINE TM VNP#M 67 Epidermal Growth Factor Receptor 66 Bayer Onyx 66 ® lenalidomide 66 visilizumab 66 calcineurin inhibitors 66 Paraplatin ® 66 Cytoxan 66 caspofungin 66 capecitabine Xeloda 66 Phase Ib clinical 66 Nanobody 66 HuMax CD# 66 trastuzumab Herceptin 66 Crizotinib 66 tenofovir Viread 66 Gliadel Wafer 66 fulvestrant 66 Allovectin 7 ® 66 XELOX 66 Bosutinib 66 fluvastatin 66 ularitide 66 ALN HPN 66 Vidaza R 66 ORENCIA ® 66 tesmilifene 66 Abiraterone acetate 66 therapeutic regimens 66 Phase IIb Trial 66 #D#C# 66 Platinol ® cisplatin 66 Neulasta ® 66 mTOR inhibitors 66 BEMA TM LA 66 R lenalidomide 66 Alkeran 66 rNAPc2 66 mutated KRAS 66 Eculizumab 66 aclidinium 66 pegylated liposomal doxorubicin PLD 66 alemtuzumab Campath 66 Toxicities 66 antitumor effect 66 Pivotal Phase 66 piperacillin tazobactam 66 olmesartan 66 irinotecan containing 66 pemetrexed 66 nilotinib Tasigna 66 PEGylated anti 66 Epirubicin 66 TREANDA 66 basiliximab 66 EGFR tyrosine kinase inhibitors 66 EGFR tyrosine kinase inhibitor 66 refractory cutaneous T 66 Neurodex 66 plus gemcitabine 66 LEP ETU 66 interleukin IL -# 66 MEK inhibitor RDEA# 66 PROSTVAC VF 66 LY# [003] 66 Fluconazole 66 HRPC 66 Amplimexon 66 Pharmacokinetics PK 66 doripenem 66 novel VDA molecule 66 5 Fluorouracil 66 tigecycline 66 canakinumab 66 prostate cancer HRPC 66 INTELENCE 66 Phase Ib study 66 romidepsin 66 amprenavir 66 ruxolitinib 66 PegIFN 66 Metastatic Melanoma 66 investigational hepatitis C 66 obatoclax 66 flutamide 66 Hycamtin 66 BEACOPP 66 intravenous cyclophosphamide 66 Vicriviroc 66 Tamibarotene 66 Investigational Compound 66 OHR/AVR# 66 PSN# [001] 66 hA# 66 LEXIVA r 66 cyclophosphamide methotrexate 66 renal toxicity 66 Camptosar ® irinotecan 66 NVA# 66 5FU 66 metastatic malignant melanoma 66 monotherapy 66 neurologic progression 66 gemcitabine Gemzar R 66 voriconazole 66 immunoconjugate 66 antitumor activity 66 CIMZIA ™ 66 orBec 66 pharmacokinetic interactions 66 ribavirin USP 66 chemotherapy cisplatin 66 aprepitant 66 vemurafenib 66 azathioprine 66 lesinurad 66 mg kg dose 66 IgG1 monoclonal antibody 66 Epivir 66 Lenocta 66 TYKERB 66 Adalimumab 66 evaluating Xcytrin 66 sitaxsentan 66 Antiviral Activity 66 ThermoDox R 66 IFN α 66 Albuferon TM 66 CD# antibody [001] 66 Combination REOLYSIN R 66 Luteinizing Hormone Releasing Hormone 66 assessing T DM1 66 TroVax ® 66 INSPIRE Trial Phase III 66 Novel Oral 66 Corlux 66 Daclizumab 66 REYATAZ R 66 Capesaris 66 interferon ribavirin 66 TG# [003] 66 antiangiogenic therapy 66 EZN 66 plus prednisone prednisolone 66 mCRC patients 66 Decitabine 66 pramlintide metreleptin combination 66 Phase IIIb clinical 66 antibody MT# 66 TRV# [001] 66 Elitek 66 EndoTAGTM 1 66 candesartan cilexetil 66 MKC# MT 66 DXL# 66 cytokine refractory 66 telaprevir VX 66 Dacogen decitabine 66 ENMD # 66 seliciclib 66 peginterferon alfa 2b 66 Hsp# Inhibitor 66 Pivotal Phase III 66 urocortin 2 66 esomeprazole Nexium 66 APTIVUS R 66 T#I [002] 66 PNP inhibitor 66 antitumor effects 66 cariprazine 66 PDE4 inhibitor 66 KRAS mutations occur 66 REVLIMID ® 66 ALN TTR 66 dacarbazine DTIC 66 radezolid 66 metastatic pancreatic 66 palifermin 66 infliximab Remicade 66 IMGN# 66 Naive Patients 66 ISTODAX 66 vinorelbine 66 chemotherapy FOLFOX 66 cannabinor 66 TAFA# 66 immunomodulatory therapy 66 Thiovir 66 SCCHN 66 phase Ib 66 iloprost 66 pimozide 66 cyclophosphamide Cytoxan 66 MEK Inhibitor 66 PEG interferon 66 Pirfenidone 66 BNC# 66 dose cohort 66 chemotherapy gemcitabine 66 mGluR5 NAM 66 IAP inhibitor 66 IMiDs ® 66 dose cohorts 66 anti angiogenic agents 66 Brentuximab Vedotin SGN 66 Pivotal Study 66 venlafaxine ER 66 daunorubicin 66 alvimopan 66 Zarnestra 66 itraconazole Sporanox 66 orally administered inhibitor 66 taxane chemotherapy 66 5-FU/LV 66 PEG Interferon lambda 66 PROSTVAC TM 66 Abiraterone Acetate 66 miconazole Lauriad ® 66 carboplatin chemotherapy 66 RezularTM 66 busulfan 66 Nilotinib 66 FOLFIRI chemotherapy 66 non nucleoside inhibitor 66 Patients Treated With 66 Cutaneous T 65 AZT zidovudine Retrovir 65 Insegia 65 Apaziquone 65 Flu Cy 65 phase IIb III 65 INFERGEN 65 fludarabine 65 Torisel temsirolimus 65 Ocrelizumab 65 refractory NSCLC 65 Neoadjuvant 65 bezafibrate 65 Pegloticase 65 Betaferon ® 65 #mg BID [001] 65 TOCOSOL Camptothecin 65 figitumumab 65 VELCADE melphalan 65 octreotide acetate 65 Granulocyte Colony Stimulating Factor 65 meropenem 65 omega interferon 65 p# biomarker 65 systemic anaplastic large 65 HMG CoA reductase inhibitors 65 TNF inhibitor 65 cancer immunotherapies 65 vinca alkaloid 65 Ixabepilone 65 EGFR inhibitors 65 antiproliferative effects 65 OncoVex 65 abatacept Orencia 65 metastatic malignant 65 Talabostat 65 Fludarabine 65 p# MAP kinase inhibitor 65 temozolomide 65 Anti Tumor 65 mg RDEA# 65 CHOP chemotherapy 65 paclitaxel carboplatin 65 XL# XL# 65 esophageal candidiasis 65 glatiramer acetate 65 antifibrotic 65 Anidulafungin 65 ara C 65 midstage trials 65 metastatic castrate resistant 65 recurrent glioma 65 azacytidine 65 imatinib mesylate 65 HIF PHI 65 Tocosol Paclitaxel 65 HCD# [002] 65 peginterferon ribavirin 65 trastuzumab 65 polymerase inhibitor 65 PRTX 65 dose escalation clinical 65 Pafuramidine 65 oral chemotherapeutic agent 65 Roche Xeloda 65 R Saizen R 65 isoproterenol 65 Zometa zoledronic acid 65 multitargeted 65 salmeterol fluticasone 65 PS# [001] 65 Paliperidone Palmitate 65 phase IIb study 65 INC# 65 iclaprim 65 BARACLUDE R 65 Dendreon Provenge 65 investigational oral hepatitis C 65 PI3K/Akt pathway inhibitor 65 angiotensin receptor blocker ARB 65 SinuNase 65 3TC lamivudine Epivir 65 tafamidis 65 8mg/kg 65 CD3 monoclonal antibody 65 clevidipine 65 Vilazodone 65 Denufosol 65 vascular disrupting agent 65 HERCEPTIN 65 FASLODEX 65 heavily pretreated 65 PPAR gamma agonist 65 BENICAR HCT 65 Xanafide 65 Metastatic Colorectal Cancer 65 II Clinical Trial 65 Fluorouracil 65 Aurora Kinase 65 abatacept 65 tarenflurbil 65 Tavocept 65 Aloxi injection 65 HuMax CD4 65 cMET 65 custirsen 65 PREZISTA rtv 65 ceftaroline 65 vismodegib 65 ON #.Na 65 febuxostat 65 Protexia R 65 Neulasta R 65 Ophena TM 65 OvaRex ® MAb 65 oral antidiabetic 65 ARIMIDEX 65 ELND# 65 elacytarabine 65 MEK inhibitor 65 Tolvaptan 65 xanthine oxidase inhibitor 65 huN# DM1 65 Nitazoxanide 65 Bosentan 65 corticosteroid therapy 65 darapladib 65 Azixa MPC 65 Kinoid 65 Pradefovir 65 Sanofi Aventis Taxotere 65 4mg/kg 65 mcg QD 65 ALVESCO 65 ZD# [001] 65 Androxal TM 65 mometasone 65 BrachySil 65 sapacitabine 65 adjuvant colon cancer 65 IV Busulfex 65 ponatinib 65 2 methoxyestradiol 65 reslizumab 65 Roche Actemra 65 Tesetaxel 65 nucleotide analogue 65 trastuzumab DM1 T DM1 65 tipranavir r 65 AMD# [003] 65 nonclinical studies 65 SUTENT 65 Advaxis Phase 65 azilsartan medoxomil 65 Natalizumab 65 refractory prostate cancer 65 interferon alfa 2b 65 Ranolazine 65 selective androgen receptor modulator 65 idraparinux 65 doxorubicin HCl liposome injection 65 Symadex 65 doxorubicin cyclophosphamide